# VTEU: PHASE II VACCINE TRIAL FOR INFLUENZA

> **NIH NIH N01** · UNIVERSITY OF MARYLAND BALTIMORE · 2022 · $5,000

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations.

## Key facts

- **NIH application ID:** 10703283
- **Project number:** 272201300022I-P00002-27200021-1
- **Recipient organization:** UNIVERSITY OF MARYLAND BALTIMORE
- **Principal Investigator:** KAREN KOTLOFF
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $5,000
- **Award type:** —
- **Project period:** 2017-07-28 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10703283

## Citation

> US National Institutes of Health, RePORTER application 10703283, VTEU: PHASE II VACCINE TRIAL FOR INFLUENZA (272201300022I-P00002-27200021-1). Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/grant/nih/10703283. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*